US B2B Growth Sol-Millennium recently launched a dedicated U.S. B2B e-commerce platform and eshop, creating a direct sales channel to healthcare facilities, clinics, and distributors. This presents a strategic entry point for targeted outreach to procurement teams and purchasing managers in the U.S. market.

Safety Device Expansion The company focuses on safety syringes, needles, and blood collection devices under Sol-Care and Sol-Guard, including veterinary products through Sol-Vet. There is a clear opportunity to cross-sell safety innovations to both human healthcare and veterinary customers, expanding bundled offerings.

Global Footprint With a global presence, regional offices in Brazil, Poland, and the USA, plus a European R&D center in Switzerland, Sol-Millennium can support multinational customers with localized compliance, training, and procurement, enabling enterprise-level contracts and regional distribution deals.

Frontline Collaboration Close collaboration with frontline healthcare professionals drives product improvements and new innovations. Leverage clinician partnerships for pilot programs, education partnerships, and early-access trials to accelerate adoption of new safety devices.

Insulin Delivery Opportunity Recent needle-free injection device launches for insulin in Canada indicate a gateway product line that can expand into North American clinics, endocrinology practices, and diabetes care networks, offering synergy with existing safety needle offerings and training materials.